title: FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals.
abstract: Insulin injection pens have improved the ease and convenience of administering insulin for people with diabetes. This article reviews the data on a new prefilled insulin pen, FlexTouch®. FlexTouch has a novel injection mechanism with no push-button extension and a lower injection force than other prefilled pens, and other features including an end-of-dose click; a large dose display; color-coded pens to distinguish different insulin types; an ergonomic design; and compatibility with both NovoTwist® needles and most screw-thread needles. FlexTouch has been demonstrated to deliver insulin consistently and accurately at minimum, half-maximum and maximum doses. In usability studies recruiting patients and healthcare professionals, FlexTouch was easier to use and instilled more confidence than other prefilled pens, and was preferred to other prefilled pens. FlexTouch was also found to be easier to use and was preferred for learning and teaching to use.
authors.affiliation: AMCR Institute Inc., 700 West El Norte Parkway Suite 201, Escondido, CA 92026, USA. tbailey@amcrinstitute.com
authors.forename: Timothy
authors.initials: T
authors.lastname: Bailey
authors.forename: Carlos
authors.initials: C
authors.lastname: Campos
mesh_terms: D000465:Algorithms; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004209:Disposable Equipment; D016503:Drug Delivery Systems / Q000295:instrumentation*; D004867:Equipment Design; D006801:Humans; D007003:Hypoglycemia / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007279:Injections, Subcutaneous / Q000295:instrumentation; D007328:Insulin / Q000008:administration & dosage*; D008833:Microcirculation; D017060:Patient Satisfaction; D010465:Perception; D015203:Reproducibility of Results
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin